35.172.217.174
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Glaucoma
Trending Topics
Task force says more researched needed before recommendations made on glaucoma, impaired vision screening
Statins improves Graves’ orbitopathy outcomes in patients with active eye disease
FDA approves Xipere for treatment of macular edema associated with uveitis
Many patients have lapses in care after ranibizumab injections for PDR
Brolucizumab interim treatment yields anatomic improvements
-Advertisement-
Retina
October 25, 2021

The U.S. Food and Drug Administration (FDA) approved Xipere (triamcinolone acetonide injectable suspension; Bausch + Lomb) for suprachoroidal use for the treatment of macular edema associated with uveitis, according to a press release....

-Advertisement-
-Advertisement-
-Advertisement-
OSD / Dry Eye
October 18, 2021

This is the first and only nasal spray approved for the treatment of the signs and symptoms of dry eye disease. The U.S. Food and Drug Administration has approved Tyrvaya (varenicline solution; Oyster...

-Advertisement-
-Advertisement-
-Advertisement-
Glaucoma
October 26, 2021

The U.S. Preventive Services Task Force issued a draft recommendation statement saying that more research is needed before making a recommendation for or against screening in primary care for people who have not...

-Advertisement-
-Advertisement-
-Advertisement-

Polls

Poll: Which session at the Top 10 Things I Wish I Knew Sooner virtual meeting are you looking forward to most?
Sep 12, 2021

Podcasts

David Pyott and Jim Mazzo talk newly formed Ophthalmology Foundation
Apr 20, 2021

Quizzes

Photo Quiz: June 2021
Jun 28, 2021

Videos

AMD: Genetic Testing & Controversies Surrounding the Test Webinar + Best of the Best Q+A
Sep 28, 2021
Oculoplastics
September 29, 2021

In this case report, a 50-year-old woman presented with periorbital swelling and proptosis that had lasted for 2 months and began 3 days after receiving her second COVID-19 vaccination. The patient had a...

-Advertisement-
-Advertisement-
-Advertisement-
Pediatrics
October 20, 2021

The U.S. Food and Drug Administration has approved Luminopia One (Luminopia) as a prescription therapy to improve vision in children with amblyopia (lazy eye), the leading cause of vision loss in children, according...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-